David Krauth, MPH
Clinical Research Coordinator
Medicine
School of Medicine

Publications (8)

Top publication keywords:
Drug IndustrySample SizeRisk AssessmentDrug Evaluation, PreclinicalHydroxymethylglutaryl-CoA Reductase InhibitorsPublication BiasConflict of InterestAtherosclerosisBiasToxicity TestsSmoking CessationInformation DisseminationResearch DesignMEDLINEMass Media

• Overview of state policies requiring smoking cessation therapy in psychiatric hospitals and drug abuse treatment centers.
  Tobacco induced diseases 2015 Krauth D, Apollonio DE
• Accuracy of popular media reporting on tobacco cessation therapy in substance abuse and mental health populations.
  BMJ open 2015 Krauth D, Apollonio D
• Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis.
  BMC medical research methodology 2015 Anglemyer AT, Krauth D, Bero L
• Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles.
  Systematic reviews 2014 Forsyth SR, Odierna DH, Krauth D, Bero LA
• The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-Analysis.
  Evidence-based preclinical medicine 2014 Abdel-Sattar M, Krauth D, Anglemyer A, Bero L
• Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond.
  Environmental health perspectives 2014 Krauth D, Woodruff TJ, Bero L
• Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis.
  PLoS biology 2014 Krauth D, Anglemyer A, Philipps R, Bero L
• Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review.
  Environmental health perspectives 2013 Krauth D, Woodruff TJ, Bero L